CA2504076C - Reseau elastomere degradable - Google Patents

Reseau elastomere degradable Download PDF

Info

Publication number
CA2504076C
CA2504076C CA 2504076 CA2504076A CA2504076C CA 2504076 C CA2504076 C CA 2504076C CA 2504076 CA2504076 CA 2504076 CA 2504076 A CA2504076 A CA 2504076A CA 2504076 C CA2504076 C CA 2504076C
Authority
CA
Canada
Prior art keywords
elastomer
polymer
poly
cross
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2504076
Other languages
English (en)
Other versions
CA2504076A1 (fr
Inventor
Brian G. Amsden
Gauri Prasad Misra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University at Kingston
Original Assignee
Queens University at Kingston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University at Kingston filed Critical Queens University at Kingston
Priority to CA 2504076 priority Critical patent/CA2504076C/fr
Priority to US11/403,203 priority patent/US20060233857A1/en
Publication of CA2504076A1 publication Critical patent/CA2504076A1/fr
Application granted granted Critical
Publication of CA2504076C publication Critical patent/CA2504076C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246Intercrosslinking of at least two polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
CA 2504076 2005-04-14 2005-04-14 Reseau elastomere degradable Expired - Fee Related CA2504076C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA 2504076 CA2504076C (fr) 2005-04-14 2005-04-14 Reseau elastomere degradable
US11/403,203 US20060233857A1 (en) 2005-04-14 2006-04-13 Degradable elastomeric network

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2504076 CA2504076C (fr) 2005-04-14 2005-04-14 Reseau elastomere degradable

Publications (2)

Publication Number Publication Date
CA2504076A1 CA2504076A1 (fr) 2006-10-14
CA2504076C true CA2504076C (fr) 2014-12-09

Family

ID=37101432

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2504076 Expired - Fee Related CA2504076C (fr) 2005-04-14 2005-04-14 Reseau elastomere degradable

Country Status (1)

Country Link
CA (1) CA2504076C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113181157B (zh) * 2021-05-24 2023-04-07 万华化学集团股份有限公司 一种维生素a乙酸酯微囊的制备方法
CN114306724B (zh) * 2021-12-30 2022-11-11 上海汇禾医疗科技有限公司 一种可缓释药物的栓塞微球及其制备方法

Also Published As

Publication number Publication date
CA2504076A1 (fr) 2006-10-14

Similar Documents

Publication Publication Date Title
US20060233857A1 (en) Degradable elastomeric network
Agarwal et al. Injectable implants for the sustained release of protein and peptide drugs
Buwalda et al. Hydrogels in a historical perspective: From simple networks to smart materials
Kempe et al. In situ forming implants—an attractive formulation principle for parenteral depot formulations
Hatefi et al. Biodegradable injectable in situ forming drug delivery systems
Yu et al. Injectable hydrogels as unique biomedical materials
Bos et al. In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy
Tamada et al. The development of polyanhydrides for drug delivery applications
Ravi Kumar et al. Polymeric controlled drug-delivery systems: perspective issues and opportunities
US6984393B2 (en) Biodegradable elastomer and method of preparing same
US6497903B1 (en) Hydrolysable hydrogels for controlled release
EP0863933B1 (fr) Nouveaux hydrogels a base de copolymeres trisequences, leur preparation et leur application
Ferreira et al. Photocrosslinkable polymers for biomedical applications
Bos et al. Tissue reactions of in situ formed dextran hydrogels crosslinked by stereocomplex formation after subcutaneous implantation in rats
Sinha et al. Bioabsorbable polymers for implantable therapeutic systems
US20100255098A1 (en) Stereocomplex hydrogels
EP1891941A1 (fr) Formulations des gel aqueuses comprenant des microsphères
Loh et al. Biodegradable thermogelling polymers
JP2011526288A (ja) エキセナチド及び他のポリペプチド類の持続的送達
Amsden Novel biodegradable polymers for local growth factor delivery
Ghosh Recent research and development in synthetic polymer-based drug delivery systems
AL et al. Biodegradable polymers: Which, when and why?
Jerbic Biodegradable synthetic polymers and their application in advanced drug delivery systems (DDS)
US20170035895A1 (en) Dehydrated hydrogel inclusion complex
CA2504076C (fr) Reseau elastomere degradable

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200831